https://www.live-feeds.com/feed/approval-of-a-cheap-version-of-hiv-prevention-shot-lenacapavir-raises-hopes-in-low-income-countriesContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/approval-of-a-cheap-version-of-hiv-prevention-shot-lenacapavir-raises-hopes-in-low-income-countrieshttps://www.live-feeds.com/feed/approval-of-a-cheap-version-of-hiv-prevention-shot-lenacapavir-raises-hopes-in-low-income-countries#u187131Mon, 09 Nov 2026 05:11:11 +0000The US FDA has approved a generic version of lenacapavir, a twice-a-year shot to prevent HIV, making it available inexpensively and more quickly in 120 low- and middle-income countries. This approval is a significant step towards ending AIDS. Dr Reddy's obtained tentative FDA approval for the generic version. The medication, developed by Gilead Sciences, will help increase access to HIV prevention in lower-income countries.Why it mattersThe approval of lenacapavir is crucial in the fight against HIV, particularly in low-income countries where access to expensive medication is limited. Acc